About Drugs Made In America Acquisition II Corp. Right
Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
CEO
Lynn Stockwell
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Asset Management
Sector Financial Services
Went public December 4, 2025
Full time employees 0
Ratings Snapshot
Rating : C
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 5
Overall Score 2
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0
Market Cap $7.87 M
52w High $0.13
52w Low $0.11
P/E 0
Volume 3.84K
Outstanding Shares 65.58M
About Drugs Made In America Acquisition II Corp. Right
Drugs Made In America Acquisition II Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2024 and is based in Fort Lauderdale, Florida.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $0 | $155.51K ▲ | $-46.16K ▼ | 0% | $-0 ▼ | $-46.16K ▼ |
| Q2-2025 | $0 | $38.07K ▼ | $-38.07K ▲ | 0% | $-0 ▲ | $-38.07K ▲ |
| Q1-2025 | $0 | $59.33K ▲ | $-59.33K ▼ | 0% | $-0 ▼ | $-59.33K ▼ |
| Q3-2024 | $0 | $41.68K | $-41.68K | 0% | $-0 | $-41.68K |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $315.09K ▲ | $501.01M ▲ | $18.18M ▲ | $482.83M ▲ |
| Q2-2025 | $4.39K ▼ | $113.39K ▲ | $327.51K ▲ | $-214.12K ▼ |
| Q1-2025 | $6.99K | $105.09K | $281.14K | $-176.05K |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-46.16K | $-690.73K | $-500M | $501M | $310.69K | $-690.73K |
CEO
Lynn Stockwell
Compensation Summary
(Year )
Total Compensation (Unknown At The Moment)
Industry Asset Management
Sector Financial Services
Went public December 4, 2025
Full time employees 0
Ratings Snapshot
Rating : C
Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 5
Overall Score 2
Price Target
Target High $0
Target Low $0
Target Median $0
Target Consensus $0